The Neural and Behavioral Correlates of How Donepezil Modulates Memory and Inhibitory Efficiency in the Context of 24 Hours of Sleep Deprivation.
Phase of Trial: Phase IV
Latest Information Update: 05 Aug 2016
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease; Attention deficit and disruptive behaviour disorders; Dementia; Migraine; Vascular dementia
- Focus Biomarker; Pharmacodynamics
- 06 Dec 2008 New trial record.